Editorial-Details (JBB)

Wenjing Tang

Smith School of Chemical and Biomolecular Engineering
Cornell University
China

Biography

Dr. Wenjing Tang is a bioengineer and postdoctoral researcher in the Smith School of Chemical and Biomolecular Engineering at Cornell University. Her research focuses on developing innovative drug delivery systems, nanomedicine platforms, and immunotherapy approaches for the treatment of infectious and inflammatory diseases. She has made significant contributions to immune cell mediated drug delivery, transtympanic therapies for otitis media, and biofilm targeted treatments. Dr. Tang has authored numerous publications in leading journals, secured patent applications, and actively serves as a reviewer for several international scientific journals. She is currently an Ignite Fellow at Cornell University, leading the translational development of non invasive therapies for otitis media.

Research Interest

Drug Delivery Systems, Nanomedicine, Immunotherapy, Bioinspired Nanomaterials, Liposomal Drug Delivery, Immune Cell Mediated Therapeutics, Otitis Media Treatment, Biofilm Targeted Therapies, Biomaterials Engineering, Translational Biomedical Research, Antimicrobial Therapeutics, Pharmaceutical Nanotechnology

ISSN

ISSN No: 2996-0339

Journal Information

  • Frequency: Monthly
  • Publication: Online & Print
  • Impact Factor (2024): 0.247
  • Journal Type: Open Access
No Plagiarism Badge Creative Commons CC BY License
Reviewer Icon